Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angiogenesis

Showing results (731-740 of 1,256) with videos related to

Pageof 126
Sort By:
Angiogenesis|October 1, 2003
Zinc ligand-disrupted recombinant human Endostatin: potent inhibition of tumor growth, safety and pharmacokinetic profileB K Sim, W E Fogler, X H Zhou, et al.
Angiogenesis|October 1, 2003
The dormant in vivo phenotype of early stage primary human melanoma: termination by overexpression of vascular endothelial growth factorL Bayko, J Rak, S Man, et al.
Angiogenesis|October 1, 2003
Functional studies on the anti-pathoangiogenic properties of CM101H P Yan, C E Carter, E Z Wang, et al.
Angiogenesis|October 1, 2003
The angiogenic factor bFGF impairs leukocyte adhesion and rolling under flow conditionsA W Griffioen, I A Relou, H I Gallardo Torres, et al.
Angiogenesis|October 1, 2003
Angiogenesis in histologically benign squamous mucosa is a sensitive marker for nearby cervical intraepithelial neoplasiaK K Smith-McCune, Y Zhu, T Darragh
Angiogenesis|October 1, 2003
Influence of fibrin structure on the formation and maintenance of capillary-like tubules by human microvascular endothelial cellsA Collen, P Koolwijk, M Kroon, et al.
Angiogenesis|September 1, 2018
The calcium-binding type III repeats domain of thrombospondin-2 binds to fibroblast growth factor 2 (FGF2)Marco Rusnati, Patrizia Borsotti, Elisabetta Moroni, et al.
Angiogenesis|August 5, 2018
The therapeutic potential of targeting the endothelial-to-mesenchymal transitionShirley Man, Gonzalo Sanchez Duffhues, Peter Ten Dijke, et al.
Angiogenesis|May 23, 2018
Preclinical impact of high dose intermittent antiangiogenic tyrosine kinase inhibitor pazopanib in intrinsically resistant tumor modelsElaine Reguera-Nuñez, Shan Man, Ping Xu, et al.
Angiogenesis|April 7, 2018
BI1 is associated with microvascular protection in cardiac ischemia reperfusion injury via repressing Syk-Nox2-Drp1-mitochondrial fission pathwaysHao Zhou, Chen Shi, Shunying Hu, et al.
Pageof 126

Showing results (731-740 of 1,256) with videos related to

Sort By:
Pageof 126
Angiogenesis|October 1, 2003
Zinc ligand-disrupted recombinant human Endostatin: potent inhibition of tumor growth, safety and pharmacokinetic profileB K Sim, W E Fogler, X H Zhou, et al.
Angiogenesis|October 1, 2003
The dormant in vivo phenotype of early stage primary human melanoma: termination by overexpression of vascular endothelial growth factorL Bayko, J Rak, S Man, et al.
Angiogenesis|October 1, 2003
Functional studies on the anti-pathoangiogenic properties of CM101H P Yan, C E Carter, E Z Wang, et al.
Angiogenesis|October 1, 2003
The angiogenic factor bFGF impairs leukocyte adhesion and rolling under flow conditionsA W Griffioen, I A Relou, H I Gallardo Torres, et al.
Angiogenesis|October 1, 2003
Angiogenesis in histologically benign squamous mucosa is a sensitive marker for nearby cervical intraepithelial neoplasiaK K Smith-McCune, Y Zhu, T Darragh
Angiogenesis|October 1, 2003
Influence of fibrin structure on the formation and maintenance of capillary-like tubules by human microvascular endothelial cellsA Collen, P Koolwijk, M Kroon, et al.
Angiogenesis|September 1, 2018
The calcium-binding type III repeats domain of thrombospondin-2 binds to fibroblast growth factor 2 (FGF2)Marco Rusnati, Patrizia Borsotti, Elisabetta Moroni, et al.
Angiogenesis|August 5, 2018
The therapeutic potential of targeting the endothelial-to-mesenchymal transitionShirley Man, Gonzalo Sanchez Duffhues, Peter Ten Dijke, et al.
Angiogenesis|May 23, 2018
Preclinical impact of high dose intermittent antiangiogenic tyrosine kinase inhibitor pazopanib in intrinsically resistant tumor modelsElaine Reguera-Nuñez, Shan Man, Ping Xu, et al.
Angiogenesis|April 7, 2018
BI1 is associated with microvascular protection in cardiac ischemia reperfusion injury via repressing Syk-Nox2-Drp1-mitochondrial fission pathwaysHao Zhou, Chen Shi, Shunying Hu, et al.
Pageof 126